Literature DB >> 15596822

Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.

Jaehyuk Choi1, Jason Walker, Sergei Boichuk, Nancy Kirkiles-Smith, Nicholas Torpey, Jordan S Pober, Louis Alexander.   

Abstract

Infected CD4+ T cells are the primary sites of human immunodeficiency virus type 1 (HIV-1) replication in vivo. However, signals from professional antigen-presenting cells (APCs), such as dendritic cells and macrophages, greatly enhance HIV-1 replication in T cells. Here, we report that in cocultures, vascular endothelial cells (ECs), which in humans can also serve as APCs, can enhance HIV-1 production of both CCR5- and CXCR4-utilizing strains approximately 50,000-fold. The observed HIV-1 replication enhancement conferred by ECs occurred only in memory CD4+ T cells, required expression of major histocompatibility complex class II (MHC-II) molecules by the ECs, and could not be conferred by fixed ECs, all of which are consistent with a requirement for EC-mediated T-cell activation via T-cell receptor (TCR) signaling. Deletion of nef (Nef-) decreased HIV-1 production by approximately 100-fold in T cells cocultured with ECs but had no effect on virus production in T cells cocultured with professional APCs or fibroblasts induced to express MHC-II. Human ECs do not express B7 costimulators, but Nef- replication in CD4(+)-T-cell and EC cocultures could not be rescued by anti-CD28 antibody. ECs act in trans to enhance wild-type but not Nef- replication and facilitate enhanced wild-type replication in naive T cells when added to T-cell or B-lymphoblastoid cell cocultures, suggesting that ECs also provide a TCR-independent signal to infected T cells. Consistent with these in vitro observations, wild-type HIV-1 replicated 30- to 50-fold more than Nef- in human T cells infiltrating allogeneic human skin grafts on human huPBL-SCID/bg mice, an in vivo model of T-cell activation by ECs. Our studies suggest that ECs, which line the entire cardiovascular system and are, per force, in frequent contact with memory CD4+ T cells, provide signals to HIV-1-infected CD4+ T cells to greatly enhance HIV-1 production in a Nef-dependent manner, a mechanism that could contribute to the development of AIDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596822      PMCID: PMC538695          DOI: 10.1128/JVI.79.1.264-276.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  Immunobiology of human vascular endothelium.

Authors:  J S Pober
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA.

Authors:  K Murakami; W Ma; R Fuleihan; J S Pober
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Authors:  J C Learmont; A F Geczy; J Mills; L J Ashton; C H Raynes-Greenow; R J Garsia; W B Dyer; L McIntyre; R B Oelrichs; D I Rhodes; N J Deacon; J S Sullivan
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

4.  Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1.

Authors:  L Alexander; Z Du; A Y Howe; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.

Authors:  M S Wyand; K Manson; D C Montefiori; J D Lifson; R P Johnson; R C Desrosiers
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Human vascular endothelial cells process and present autoantigen to human T cell lines.

Authors:  C O Savage; C J Brooks; G C Harcourt; J K Picard; W King; D M Sansom; N Willcox
Journal:  Int Immunol       Date:  1995-03       Impact factor: 4.823

Review 7.  Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  G Pantaleo; C Graziosi; J F Demarest; O J Cohen; M Vaccarezza; K Gantt; C Muro-Cacho; A S Fauci
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

8.  Angiogenic properties of human immunodeficiency virus type 1 Tat protein.

Authors:  A Albini; G Barillari; R Benelli; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.

Authors:  M D Denton; C S Geehan; S I Alexander; M H Sayegh; D M Briscoe
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

10.  HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection.

Authors:  Simon Swingler; Beda Brichacek; Jean-Marc Jacque; Catherine Ulich; Jin Zhou; Mario Stevenson
Journal:  Nature       Date:  2003-07-10       Impact factor: 69.504

View more
  10 in total

1.  Soluble Factors Secreted by Endothelial Cells Allow for Productive and Latent HIV-1 Infection in Resting CD4+ T Cells.

Authors:  John Henry Morris; Tran Nguyen; Abuoma Nwadike; Mackenzie L Geels; Derrick L Kamp; Bo Ram Kim; Jean D Boyer; Anding Shen
Journal:  AIDS Res Hum Retroviruses       Date:  2016-10-05       Impact factor: 2.205

2.  Endothelial cell stimulation overcomes restriction and promotes productive and latent HIV-1 infection of resting CD4+ T cells.

Authors:  Anding Shen; Jacob J Baker; Geoffrey L Scott; Yelena P Davis; Yen-Yi Ho; Robert F Siliciano
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.

Authors:  Jaehyuk Choi; Jason Walker; Kristina Talbert-Slagle; Paulette Wright; Jordan S Pober; Louis Alexander
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

Review 5.  The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.

Authors:  Erik R Kline; Roy L Sutliff
Journal:  J Investig Med       Date:  2008-06       Impact factor: 2.895

Review 6.  Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir.

Authors:  Kyle D Pedro; Andrew J Henderson; Luis M Agosto
Journal:  Virus Res       Date:  2019-03-21       Impact factor: 3.303

7.  Endothelial Cells Promote Productive HIV Infection of Resting CD4+ T Cells by an Integrin-Mediated Cell Adhesion-Dependent Mechanism.

Authors:  Catherine M Card; Bernard Abrenica; Lyle R McKinnon; Terry Blake Ball; Ruey-Chyi Su
Journal:  AIDS Res Hum Retroviruses       Date:  2021-10-11       Impact factor: 2.205

Review 8.  An Outlook on the Etiopathogenesis of Pulmonary Hypertension in HIV.

Authors:  Jaimee J Palakeel; Mazin Ali; Phani Chaduvula; Sanika Chhabra; Smriti Lamsal Lamichhane; Vaiishnavi Ramesh; Collins O Opara; Farhana Yaqoob Khan; Gargi Kabiraj; Humaira Kauser; Jihan A Mostafa
Journal:  Cureus       Date:  2022-07-28

Review 9.  Trained Immunity and Reactivity of Macrophages and Endothelial Cells.

Authors:  Charles Drummer; Fatma Saaoud; Ying Shao (邵颖); Yu Sun (孙宇); Keman Xu (徐克曼); Yifan Lu (路一凡); Dong Ni (倪栋); Diana Atar; Xiaohua Jiang (蒋晓华); Hong Wang (王虹); Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-31       Impact factor: 8.311

10.  Lymphatic endothelial cells promote productive and latent HIV infection in resting CD4+ T cells.

Authors:  Meghan Schilthuis; Seth Verkaik; Mackenzie Walhof; Andrew Philipose; Olivia Harlow; Derrick Kamp; Bo Ram Kim; Anding Shen
Journal:  Virol J       Date:  2018-10-03       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.